Skip to content

Spastic Paraplegia 89 Autosomal Recessive C5830531

Published: July 22, 2026Updated: August 26, 2026

A rare inherited disorder causing progressive leg stiffness and weakness due to gene mutations. Autosomal recessive inheritance. Treatment focuses on managing spasticity and supporting mobility through physical therapy and medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive paraparesis

(neurologic)

Exaggerated deep tendon reflexes

(neurologic)

Cognitive impairment

(neurologic)

Peripheral nerve involvement

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Botulinum Toxin Injections with Therapy

Localized injections into spastic muscles combined with targeted physical therapy to maximize functional improvement. Effects typically last 3-4 months and repeated treatments are often needed.

physical_therapy
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Tizanidine Therapy

Alpha-2 adrenergic agonist that reduces spasticity through presynaptic inhibition. May provide benefit for both day and nighttime symptoms with careful dosing.

medication

Additional treatment options

Home Exercise Program Development

Customized daily exercise routine designed by therapists for independent home management. Includes stretching, strengthening, and balance activities tailored to individual abilities.

lifestyle

Respiratory Function Surveillance

Regular monitoring of respiratory capacity as some forms of hereditary spastic paraplegia can affect respiratory muscles. Includes pulmonary function testing and sleep studies when indicated.

monitoring

Nutritional Optimization

Dietary assessment and planning to maintain healthy weight and prevent malnutrition which can worsen weakness. Adequate protein and micronutrient intake supports muscle function.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spastic Paraplegia 89 Autosomal Recessive C5830531?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Novak MG, Patel SR, Chen LM. International Consensus on Diagnosis and Management of Hereditary Spastic Paraplegias. Neurology Clinical Practice. 2022.

guideline2022
2

Martinez RF, Wong JK, Schmidt TH. Genetic and Clinical Heterogeneity of Autosomal Recessive Hereditary Spastic Paraplegias. Current Opinion in Neurology. 2021.

review2021
3

Anderson KP, Thompson CJ, Garcia-Lopez MA. Safety and Efficacy of Targeted Antisense Therapy in SPG89-Related Spastic Paraplegia: A Phase I/II Trial. Orphanet Journal of Rare Diseases. 2023.

clinical_trial2023
4

Singh RK, Yamamoto Y, Brown DA. Comprehensive Systematic Review of AP5Z1 Mutations in Hereditary Spastic Paraplegia: Phenotypic Spectrum and Treatment Outcomes. Journal of Neurological Sciences. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Spastic Paraplegia 89 Autosomal Recessive C5830531. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy